AI can be used to detect and grade prostate cancer

byKarolinska InstitutetMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0Researchers at Karolinska Institutet in Sw

Updated on: December 22,2023

AI can be used to detect and grade prostate cancer

byKarolinska InstitutetMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0Researchers at Karolinska Institutet in Sw

Updated on:December 22,2023

Personalized breast cancer screening could improve cancer survival and reduce overdiagnosis

by European Organisation for Research and Treatment of CancerCredit: Unsplash/CC0 Public DomainResearchers have created a model for predicting individual breast cancer risk that could be used to creat

Updated on: December 22,2023

Personalized breast cancer screening could improve cancer survival and reduce overdiagnosis

by European Organisation for Research and Treatment of CancerCredit: Unsplash/CC0 Public DomainResearchers have created a model for predicting individual breast cancer risk that could be used to creat

Updated on:December 22,2023

Switch to plant-based diet could boost prostate cancer survival

by Steven ReinbergFollowing a healthy plant-based diet after a diagnosis of prostate cancer may help prevent the disease from progressing or recurring, a new study suggests.Men who ate adiet&nbs

Updated on: December 22,2023

Switch to plant-based diet could boost prostate cancer survival

by Steven ReinbergFollowing a healthy plant-based diet after a diagnosis of prostate cancer may help prevent the disease from progressing or recurring, a new study suggests.Men who ate adiet&nbs

Updated on:December 22,2023

Scientists identify multiple cell types that may contribute to treatment resistance in prostate cancer

byeLifeA cell-by-cell tapestry of prostate cancer progression, which the authors created by applying a technique called UMAP to the entire dataset from their study. Credit: Germanos et al. (CC B

Updated on: December 27,2023

Scientists identify multiple cell types that may contribute to treatment resistance in prostate cancer

byeLifeA cell-by-cell tapestry of prostate cancer progression, which the authors created by applying a technique called UMAP to the entire dataset from their study. Credit: Germanos et al. (CC B

Updated on:December 27,2023

Head and neck cancer survivors at increased risk of suicide

by Maggie Rotermund,Saint Louis UniversityNosayaba Osazuwa-Peters, BDS, PH.D., MPH, is an assistant professor of otolaryngology at Saint Louis University School of Medicine and faculty member at

Updated on: December 18,2023

Head and neck cancer survivors at increased risk of suicide

by Maggie Rotermund,Saint Louis UniversityNosayaba Osazuwa-Peters, BDS, PH.D., MPH, is an assistant professor of otolaryngology at Saint Louis University School of Medicine and faculty member at

Updated on:December 18,2023

Going for a walk wasn't really a thing 300 years ago—the Victorians turned it into a popular pastime

by Lauren Nichola Colley,The ConversationCredit: Pixabay/CC0 Public DomainGoing for a walk is always a good idea. Perhaps, if you are lucky enough, this might be a hike along ragged cliffs or tr

Updated on: March 22,2024

Going for a walk wasn't really a thing 300 years ago—the Victorians turned it into a popular pastime

by Lauren Nichola Colley,The ConversationCredit: Pixabay/CC0 Public DomainGoing for a walk is always a good idea. Perhaps, if you are lucky enough, this might be a hike along ragged cliffs or tr

Updated on:March 22,2024

Routine HPV testing may be warranted for sinonasal cancers

(HealthDay)—Only one in four patients with sinonasal squamous cell carcinoma (SNSCC) is tested for human papillomavirus (HPV), according to a study published online Dec. 30 inCancer.Jamie R. Oli

Updated on: December 20,2023

Routine HPV testing may be warranted for sinonasal cancers

(HealthDay)—Only one in four patients with sinonasal squamous cell carcinoma (SNSCC) is tested for human papillomavirus (HPV), according to a study published online Dec. 30 inCancer.Jamie R. Oli

Updated on:December 20,2023

The AI Blind Spot in Oncology: Why Oral Cancer Remains a Diagnostic Challenge

Oral cancer continues to exact a growing toll on global health, with incidence rates rising from 3.26 per 100,000 in 1990 to 5.34 in 2021.

Updated on: August 25,2025

The AI Blind Spot in Oncology: Why Oral Cancer Remains a Diagnostic Challenge

Oral cancer continues to exact a growing toll on global health, with incidence rates rising from 3.26 per 100,000 in 1990 to 5.34 in 2021.

Updated on:August 25,2025

3-D mammography detected 34% more breast cancers in screening

byLund UniversityUsing breast tomosynthesis (3D screening) in the image to the left (one of about 50 thin cross-sectional image slices of the breast), you can see an approximately 1 cm-large tum

Updated on: December 18,2023

3-D mammography detected 34% more breast cancers in screening

byLund UniversityUsing breast tomosynthesis (3D screening) in the image to the left (one of about 50 thin cross-sectional image slices of the breast), you can see an approximately 1 cm-large tum

Updated on:December 18,2023

Pathogenesis to management of hepatocellular carcinoma

by Impact JournalsMolecular pathways and targeted therapeutics in hepatocellular carcinoma. Abbreviations: APC: antigen presenting cell; AXL is a cell surface receptor tyrosine kinase, part of the TAM

Updated on: December 22,2023

Pathogenesis to management of hepatocellular carcinoma

by Impact JournalsMolecular pathways and targeted therapeutics in hepatocellular carcinoma. Abbreviations: APC: antigen presenting cell; AXL is a cell surface receptor tyrosine kinase, part of the TAM

Updated on:December 22,2023

Cancer biomarker data is not diverse, with implications for immunotherapy patients from underrepresented groups

byCell PressCredit: Pixabay/CC0 Public DomainHigh tumor mutational burden—the number of mutations found inside cancer cells—may not generalize as an accurate biomarker across diverse cancer pati

Updated on: December 18,2023

Cancer biomarker data is not diverse, with implications for immunotherapy patients from underrepresented groups

byCell PressCredit: Pixabay/CC0 Public DomainHigh tumor mutational burden—the number of mutations found inside cancer cells—may not generalize as an accurate biomarker across diverse cancer pati

Updated on:December 18,2023

Residual cancer burden after neoadjuvant therapy can accurately predict breast cancer survival

byUniversity of Texas M. D. Anderson Cancer CenterW. Fraser Symmans, M.D. Credit: MD Anderson Cancer CenterResearchers from The University of Texas MD Anderson Cancer Center today reported resul

Updated on: December 22,2023

Residual cancer burden after neoadjuvant therapy can accurately predict breast cancer survival

byUniversity of Texas M. D. Anderson Cancer CenterW. Fraser Symmans, M.D. Credit: MD Anderson Cancer CenterResearchers from The University of Texas MD Anderson Cancer Center today reported resul

Updated on:December 22,2023